1. |
Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016, 13(10): e1002152.
|
2. |
Moran TJ. Autopsy incidence of pulmonary embolism in tuberculosis. Dis Chest, 1950, 18(2): 171-173.
|
3. |
Dentan C, Epaulard O, Seynaeve D, et al. Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes. Clin Infect Dis, 2014, 58(4): 495-501.
|
4. |
Purayil NK, Sirajudeen J, Al Arbi KM, et al. Venous Thromboembolism: An Unusual Presentation of Pulmonary Tuberculosis. Cureus, 2021, 13(3): e14092.
|
5. |
Kumarihamy KW, Ralapanawa DM, Jayalath WA. A rare complication of pulmonary tuberculosis: a case report. BMC Res Notes, 2015, 8: 39.
|
6. |
Chaudhary A, Desai U, Joshi JM. Venous thromboembolism due to hyperhomocysteinaemia and tuberculosis. Natl Med J India, 2017, 30(3): 139-141.
|
7. |
Sharma A, Sharma V. Abdominal aortic thrombosis and tuberculosis: an uncommon association. Gastroenterol Rep (Oxf), 2014, 2(4): 311-312.
|
8. |
White NW. Venous thrombosis and rifampicin. Lancet (London, England), 1989, 334(8660): 434-435.
|
9. |
Alawad MJ, Albuni MK, Subahi EA, et al. Rifampicin-Induced Pulmonary Embolism: A Rare Side Effect. Cureus, 2021, 13(10): e18904.
|
10. |
郑婷婷, 叶晓芬, 金美玲, 等. 临床药师参与1例结核性胸膜炎合并肺栓塞病例的药物治疗分析. 药物流行病学杂志, 2020, 29(8): 556-558.
|
11. |
Kvasnicka T, Malikova I, Zenahlikova Z, et al. Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions. Curr Drug Metab, 2017, 18(7): 636-642.
|
12. |
Altena R, Van Roon E, Folkeringa R, et al. Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring. Haematologica, 2014, 99(2): e26-27.
|
13. |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南. 中华医学杂志, 2018, 98(14): 1060-1087.
|